Eglesia, Severina .
HRN: 21-95-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2022
CIPROFLOXACIN 500MG (TAB)
10/14/2022
10/20/2022
PO
500mg
BID
CAP-MR; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes